News
News Articles 1 - 10 of 160
Apr
Read more
Decompensated cirrhosis: an update of the BSG/BASL admission care bundle.
View the open access paper on the Frontline Gastroenterology website here > Decompensated cirrhosis: an update of the BSG/BASL admission care bundle | Frontline Gastroenterology
Decompensated Cirrhosis Care Bundle - First 6 hour
Download a copy here: Download Decompensated Cirrhosis Care Bundle 13-1-25.docx
NB: if you are using Chrome and the document fails to open click > Here
or contact admin@basl.org.uk to request a word version.
Apr
Read more
The James Lind Alliance survey to prioritise unanswered research questions for liver cirrhosis is now open.
Whether you're a healthcare professional, patient, carer, family member, or researcher, all opinions matter.
What do you think are the priorities for liver cirrhosis research?
We are asking you to select the questions you think are important from a list of 38 possible research questions, then from your long list, choose your top 10 most important questions.
We also ask you to give some information about yourself so that we will know if the survey is reaching a wide audience and to help us target groups wherethere are a low number of responses. You can choose not to answer these questions.
The survey should only take 10 – 15 minutes.
Take the survey: https://www.surveymonkey.com/r/SMMF6XJ
Closes: May 2nd 2025
Apr
Read more
The European Network for the Study of Cholangiocarcinoma is currently performing a Delphi consensus study on artificial intelligence for biliary tract cancers.
We are seeking clinicians, researchers, patients, industrial representatives, and regulatory professionals to participate in a quick survey to tell us about their perceptions and concerns about AI in this cancer.
Our survey will open on April 9th (first day of Cholangiocarcinoma Foundation annual meeting in USA) and close on May 9th (final day of AMMF Cholangiocarcinoma Charity annual meeting in UK).
Please find the QR code in the poster below and a link to the survey here: https://www.surveymonkey.com/r/CGRMDVS
Mar
Read more
The FSRH Clinical Effectiveness Unit is currently updating their guideline on the safety of contraceptive methods (the UKMEC). The UKMEC considers safety of use of contraceptive methods by individuals with a variety of personal characteristics or medical conditions: UK Medical Eligibility Criteria for Contraceptive Use.
They would like to secure some input from a liver disease expert to advise their Guideline Development Group and they would be very grateful for any help BASL members can give if someone is willing to assist them.
They are seeking a topic expert with a broad knowledge of liver disease who could advise our Guideline Development Group on the following areas:
- Cholestasis
- Viral hepatitis
- Cirrhosis
- Liver tumours
It would involve an initial meeting with their Clinical Director and systematic reviewer to consider the evidence (about an hour) in April/early May. They would also ask the topic expert to attend, if possible, part of their UKMEC Guideline Development Group meeting, which is taking place on the afternoon of Monday 9 June 2025 (for a slot of about 1 hour). They would also ask the expert to review relevant sections of draft text for the guideline subsequently, if it is agreed that revisions are needed.
Participating in this project offers an opportunity to work with leading UK and international experts on national guidance as well as those from other specialties, gain experience in guideline development and be acknowledged for your contribution in the final guideline document.
The topic expert must be a consultant clinician currently working in the specified field. The topic expert must also be in good standing with the relevant professional body and not subject to fitness to practise proceedings. Previous experience in the development of guidelines would be welcome but is not essential.
Please note the role isn’t remunerated.
They would be delighted if one of our members would be able to help.
If you are interested in assisting please contact: ceu@fsrh.org .
Mar
Read more
There are challenges that are unique to female patients as they go through the organ transplant process. A research team at the University of Edinburgh are carrying out a study, funded by NHS Blood and Transplant, to gain a greater understanding of their experiences and needs at different stages of this process and identify where and how improvements can be made to address these.
They are inviting healthcare professionals who treat or support transplant patients to express interest in participating in an online workshop. At the workshop, they will present findings from their qualitative survey on female transplant patients' experiences and needs, asking staff to work together to discuss the findings and identify key priority areas for action to ensure that these are addressed to improve the experience for female patients.
Please click on the link below to find out more about the study and what is involved in taking part:
https://app.onlinesurveys.jisc.ac.uk/s/edinburgh/workshop-for-transplant-staff
Feb
Read more
The British Liver Transplant Group (BLTG) is supporting the UK Organ Donation and Transplant Research Network (UKODTRN) to obtain as broad and complete a picture of all PPIE activity in the transplant field and ask that you complete their survey below.
Meaningful patient and public involvement and engagement (PPIE) is essential for our research. The UKODTRN is conducting a survey to map PPIE activity and infrastructure across the UK in the field of organ donation and transplantation research to ensure it is accessible, useful and relevant to our research community.
We would love to hear your views. Please click on the link below to complete the survey, which should take no longer than 10 minutes.
Take part in the survey > Here .
Many thanks,
UKODTRN
Feb
Read more
The Institute of Alcohol Studies have published a new video explaining the impact of alcohol on our healthcare services.
The video features Julia Sinclair, Professor of Addiction Psychiatry and Chair of the RCPsych Addiction Faculty, Dr Dominique Florin, Medical Director of the Medical Council on Alcohol and Sir Ian Gilmore, Profess or of Hepatology and Chair of the AHA and the MCA, and explores service fragmentation, the consequences of underfunding, and the steps needed to rebuild effective pathways to care. It makes the case for a national alcohol strategy to ensure that people experiencing alcohol dependence receive the support they need.
View on YouTube here > The Impact of Alcohol on our Healthcare Services: Explained.
Or on the Institute of Alcohol Studies website.
Feb
Read more
Following the recent round of nominations for new members to join the BLNA committee, there are more than 4 candidates for the 4 available posts and therefore a vote by the BASL BLNA membership will now take place.
BASL BLNA members can take part in the voting and today (11th February 2025) these members have been sent a communication containing the voting link.
Members can vote for up to 4 candidates and your candidates are:
• Sara Bardell
• Katharine Caddick
• Bryony Chapman
• Grace Clarke
• Megan De Los Reyes
• Rebekah Hill
• Teesha Joshy
• Laura Kent
• Amy Teague
• Ane Zamalloa
The deadline for voting is 09:00hrs on Monday 3rd March 2025. The results with be announced in March 2025.
Please contact admin@basl.org.uk if you have not received your voting link.
Feb
Read more
Calling all innovators in Cancer Surgery
BASO~ACS proudly announces the opening of submissions for 2025 round of the BASO/Rosetrees Research Grants in Cancer Surgery, in partnership with esteemed Rosetrees Trust.
They are seeking innovative research projects in surgical oncology that will develop further towards Clinical Translation. They invite multidisciplinary applications and ones that demonstrate an important improvement in delivery of cancer care or improvement in surgical treatment.
Up to £50,000 is up for grabs! This generous amount will be divided among one or more deserving applicants, based on the excellence of submissions received.
Successful projects will be eligible for inclusion in the NIHR Portfolio. Plus, we encourage applicants to seek support from the esteemed Royal College of Surgeons of England Surgical SITU Interventional Trials Unit (SITU).
Submission closes on 2nd May 2025.
For information on the grant process, eligibility, and to apply, visit BASO Website or email us at admin@baso.org.uk .
Jan
Read more
Pabrinex IV will be out of stock from July/ August 2024 until September 2025, due to supply issues relating to manufacturing regulations issued by the EU. Pabrinex IM will be permanently discontinued from December 2024. Pabrinex is only used in the UK, with thiamine IV/ IM being routinely used globally.
Licensed generic vitamins B+ C intravenous injections are now available in the UK for use.We also now have a licensed IV/ IM generic thiamine here in the UK. This can be used as an alternative to Pabrinex in people at high risk of Wernicke’s encephalopathy for treatment and prevention.
The licensed dosing may differ to the unlicensed versions we have been using however matches the amount of thiamine in Pabrinex. The following, including dosing recommendations, has been updated published online by the DHSC Specialist Pharmacy Service.
Clinical decisions and discussions should be sought when choosing between thiamine and the generic Vitamins B + C injections. There will be some patients that need the extra vitamins in the Vitamins B + C injections, however it is reassuring that the rest of the world uses IV thiamine. Cost effective prescribing is also recommended. We are also awaiting the alcohol management guideline, which should be out later in the year.
Joanna Henry, Network Lead BHPG, Gastroenterology Directorate Pharmacist, Liverpool University Hospitals NHS Trust
Sital Shah, Chair British Hepatology Pharmacy Group , Consultant Pharmacist, King’s College Hospital, London
Pabrinex spc Pabrinex Intramuscular High Potency Injection - Summary of Product Characteristics (SmPC) - (emc)
Thiamine spc Thiamine Hydrochloride 50 mg/ml solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Generic Vitamin B+ C : Public Assessment Report
